Literature DB >> 9889697

[The pharmacogenetic concept of the anxio-selective effect].

S B Seredenin, T A Voronina, G G Neznamov, Iu A Blednov, B A Badyshtov, I V Viglinskaia, M M Kozlovskaia, N V Kolotilinskaia, M A Iarkova, V L Savel'ev, T L Garibova, E A Val'dman.   

Abstract

Hereditary variations in the effects of benzodiazepine tranquilizers depending on the phenotype of an emotional stress reaction (ESR) are described. The membrane-receptor relationship showed differences between C57B1/6 with an "active" ESR phenotype and Balb/c with a "passive" ESR at the GABA benzodiazepine receptor complex level. The pharmacological results evidenced the selective anxiolytic properties of the novel drug aphobazole (2-[2-morpholyno)ethylthio]-5-ethoxybenzimidazole dihydrochloride) which produced an activating anxiolytic action in Balb/c mice whereas no behavioral changes were observed in C57B1/6 mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9889697

Source DB:  PubMed          Journal:  Vestn Ross Akad Med Nauk        ISSN: 0869-6047


  6 in total

1.  Effect of Fabomotizole on Brain Gene Expression in MR Rats in the Open Field Test.

Authors:  Yu V Vakhitova; U Sh Kuzmina; M V Voronin; L F Zainullina; S B Seredenin
Journal:  Dokl Biochem Biophys       Date:  2019-11-25       Impact factor: 0.788

2.  Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson's disease.

Authors:  Mikhail V Voronin; Ilya A Kadnikov; Dmitry N Voronkov; Sergey B Seredenin
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

3.  Deferred Administration of Afobazole Induces Sigma1R-Dependent Restoration of Striatal Dopamine Content in a Mouse Model of Parkinson's Disease.

Authors:  Ilya A Kadnikov; Ekaterina R Verbovaya; Dmitry N Voronkov; Mikhail V Voronin; Sergei B Seredenin
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

4.  Neuroprotective Properties of Quinone Reductase 2 Inhibitor M-11, a 2-Mercaptobenzimidazole Derivative.

Authors:  Mikhail V Voronin; Ilya A Kadnikov; Liana F Zainullina; Ilya O Logvinov; Ekaterina R Verbovaya; Tatyana A Antipova; Yulia V Vakhitova; Sergei B Seredenin
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

5.  Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole.

Authors:  Mikhail V Voronin; Yulia V Vakhitova; Inna P Tsypysheva; Dmitry O Tsypyshev; Inna V Rybina; Rustam D Kurbanov; Elena V Abramova; Sergei B Seredenin
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

Review 6.  Novel Technologies for Dipeptide Drugs Design and their Implantation.

Authors:  Tatiana A Gudasheva; Rita U Ostrovskaya; Sergey B Seredenin
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.